サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655536

エイコサペンタエン酸の世界市場

Eicosapentaenoic Acid

出版日
ページ情報
英文 94 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
エイコサペンタエン酸の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 94 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

エイコサペンタエン酸の世界市場は2030年までに65億米ドルに達する

2024年に35億米ドルと推定されるエイコサペンタエン酸の世界市場は、2024年から2030年にかけてCAGR 10.9%で成長し、2030年には65億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである栄養補助食品＆機能性食品アプリケーションは、CAGR 11.7％を記録し、分析期間終了までに49億米ドルに達すると予測されます。ペット＆動物用飼料アプリケーション分野の成長率は、分析期間中CAGR 7.6％と推定されます。

米国市場は推定8億9,500万米ドル、中国はCAGR14.4％で成長予測

米国のエイコサペンタエン酸市場は、2024年に8億9,500万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.1%と8.8%と予測されています。欧州では、ドイツがCAGR約8.1%で成長すると予測されています。

世界のエイコサペンタエン酸（EPA）市場- 主要動向と促進要因まとめ

エイコサペンタエン酸（EPA）とは何か、なぜ栄養と健康において重要なのか？

エイコサペンタエン酸（EPA）は、主に脂肪の多い魚や特定の藻類に含まれるオメガ3脂肪酸です。多価不飽和脂肪酸であるEPAは、人の健康、特に心臓血管機能のサポート、炎症の抑制、脳の健康促進に重要な役割を果たしています。EPAは一般に抗炎症作用が認められており、心血管疾患、関節炎、精神疾患など、さまざまな健康状態の管理において重要な栄養素となっています。さらに、EPAはエイコサノイドと呼ばれる生理活性化合物の合成に寄与することが知られており、体内のさまざまな生理的プロセスの調整に役立っています。

栄養におけるEPAの重要性は、その数々の健康効果によって浮き彫りにされています。EPAの定期的な摂取は、トリグリセリド値を低下させ、不整脈のリスクを低減し、血圧を低下させることにより、心臓の健康改善に関連しています。さらに、EPAは精神的な健康にも重要な役割を果たしており、この脂肪酸の十分な摂取量がうつ病や不安症状の緩和に役立つ可能性が示唆されています。消費者の健康志向の高まりに伴い、EPAを豊富に含む食品やサプリメントに対する需要は増加傾向にあり、EPA市場の成長を牽引しています。

EPAの主な用途と栄養ニーズへの対応は？

EPAの主な用途は、栄養補助食品、機能性食品、医薬品、動物栄養などです。栄養補助食品分野では、EPAは魚油カプセル、オキアミ油、藻類油のサプリメントとして一般的に販売されています。これらの製品は、心血管系の健康維持や炎症の抑制など、さまざまな健康効果を目的としてオメガ3系の摂取量を増やしたいと考える消費者を対象としています。EPAサプリメントの人気は、特に健康志向の高い人々や特定の健康不安を抱える人々の間で急上昇しており、こうした製品の市場拡大につながっています。

機能性食品分野では、乳製品、飲食品、スナックバーなど、さまざまな食品へのEPAの配合が増加しています。メーカー各社は、栄養価を付加した健康増進製品の潜在市場を認識しています。日常的な食品にEPAを強化することで、ブランドは有益なオメガ3系脂肪酸を食生活に取り入れる便利な方法を探している消費者に対応することができます。この動向は、総合的な健康増進を目指す消費者の間で健康的な機能性食品に対する需要が拡大し続けていることから、特に重要です。

EPAは製薬業界でも注目を集めており、治療への応用が検討されています。心血管疾患、炎症性疾患、精神疾患など、さまざまな病状の管理におけるEPAの有効性を評価するための調査が進行中です。新たな臨床研究が進めば、EPAの健康への有用性を支持するエビデンスが増加し、この重要な脂肪酸を配合した新たな医薬製剤が開発される可能性があります。

また、動物栄養分野では、ペットフードや養殖魚へのEPAの利用が拡大しています。ペット栄養分野では、関節の健康や皮膚の状態、健康全般をサポートする目的で、ドッグフードやキャットフードにEPAが配合されるようになっています。健康効果や高品質の原材料を重視するプレミアム・ペットフードの動向の高まりが、EPAのようなオメガ3系脂肪酸を強化した製品に対する需要を牽引しています。水産養殖では、EPAは飼料の品質を高め、魚の健康と成長率を向上させるため、養殖魚の成長と健康に極めて重要です。持続可能な方法で養殖された魚介類に対する世界の需要の高まりは、養殖用飼料におけるEPAの使用をさらに促進しています。

技術の進歩はEPA市場にどのような影響を与えているか？

技術の進歩は、生産方法、抽出プロセス、製品処方を改善することで、EPA市場に大きな影響を与えています。注目すべき開発のひとつに、天然由来EPAの収量と品質を向上させる抽出技術の革新があります。超臨界流体抽出や低温圧搾などの高度な方法により、製造業者は有益な特性を保持したまま高純度のEPAオイルを得ることができます。これらの抽出技術は、EPAの生産効率を向上させるだけでなく、従来の抽出方法に伴う環境への影響を軽減します。

さらに、藻類を原料とするEPAの台頭は、市場の状況を一変させつつあります。消費者の持続可能性と倫理的調達に対する意識が高まるにつれ、藻類由来のEPA製品は、魚由来の供給源に代わる有力な選択肢として支持を集めています。EPAとドコサヘキサエン酸（DHA）の両方を豊富に含む藻類油は、ベジタリアンや菜食主義者、環境意識の高い消費者にアピールする植物由来の選択肢を提供します。効率的な藻類の培養・抽出技術の開発がこの分野の成長を支え、市場におけるEPAを豊富に含む製品の利用可能性が拡大しています。

製品処方の進歩も、EPAサプリメントの有効性と生物学的利用能を高めています。乳化・カプセル化技術の革新により、体内への吸収がより容易で安定した生物学的利用能の高いEPA製品の創出が可能となっています。このような製剤は、EPAサプリメントの全体的な効果を向上させ、消費者の満足度を高めることができます。さらに、総合的な健康ソリューションを求める消費者の嗜好に応えるため、EPAとDHA、抗酸化物質、ビタミンなど、他の有益な成分を組み合わせたサプリメント製剤が一般的になりつつあります。

さらに、デジタル技術とデータ分析が、EPA市場における消費者エンゲージメントの向上と製品開拓に一役買っています。企業は消費者からのフィードバックや市場調査データを活用して、消費者の嗜好をよりよく理解し、それに応じて製品の内容を調整するようになっています。このようなデータ主導のアプローチは、メーカーがターゲットを絞ったマーケティング戦略を策定し、消費者の進化するニーズを満たす革新的なEPA製品を開発するのに役立っています。

最後に、EPAの健康効果に関する継続的な研究により、新たな用途や治療用途の可能性が見出されています。さまざまな健康状態の管理におけるEPAの役割に関する科学的研究が進むにつれて、EPAの用途は拡大していくとみられます。オメガ3系脂肪酸の重要性に対する認識の高まりと、その健康上の有用性を裏付けるエビデンスの増加は、消費者と臨床現場の双方においてEPAを豊富に含む製品の需要を促進するとみられます。

何がEPA市場の成長を牽引しているのか？

EPA市場の成長は、オメガ3系脂肪酸の健康効果に対する消費者の意識の高まり、栄養補助食品に対する需要の高まり、機能性食品分野の拡大など、いくつかの重要な要因によって牽引されています。主な促進要因のひとつは、心血管系の健康をサポートし、炎症を抑え、脳機能を促進するEPAの役割に対する認識の高まりです。消費者の健康志向が高まり、健康増進に積極的に取り組むようになるにつれて、EPAサプリメントや強化製品に対する需要は増加傾向にあります。

肥満、心臓病、精神疾患など、生活習慣に関連した健康状態の蔓延が拡大していることも、EPAの需要をさらに高めています。消費者は予防的な健康対策を求めており、オメガ3系サプリメント、特にEPAの摂取は、健康全般をサポートする有益なアプローチであると見なされるようになっています。この動向は、認知機能を維持し、慢性的な健康問題に対処するための解決策を模索している高齢化社会で特に顕著です。

機能性食品市場の拡大も、EPA市場の成長に寄与する重要な要因です。消費者は、健康上のその他の特典を提供する食品への関心を高めており、EPA強化製品に対する需要の高まりにつながっています。メーカー各社は、乳製品、スナック菓子、飲食品など、さまざまな食品にEPAを配合することでこの需要に応えています。消費者の多忙なライフスタイルに合わせた健康増進の選択肢を提供できることが、この分野の成長を後押ししています。

さらに、持続可能な植物由来の食生活を求める動向が、藻類由来のEPA製品に対する関心を高めています。ベジタリアンやビーガンのライフスタイルを採用する消費者が増えるにつれて、オメガ3脂肪酸の代替供給源に対する需要が高まっています。EPAとDHAの両方を豊富に含む藻類油は、魚類に頼らずにオメガ3摂取量を増やしたい消費者にとって、持続可能で倫理的な選択肢となります。消費者の嗜好が植物由来のものにシフトしていることから、EPA市場には今後もポジティブな影響が続くと思われます。

最後に、EPAの治療への応用を検討する現在進行中の調査や臨床研究が、市場の成長を後押ししています。特定の健康状態の管理におけるEPAの潜在的な有用性に関する新たなエビデンスが明らかになるにつれて、ヘルスケアプロバイダーはオメガ3サプリメントの摂取を推奨するようになっています。このような調査結果の積み重ねは、臨床現場におけるEPAの使用を裏付けるものであり、必須脂肪酸であるEPAの幅広い受容と活用に寄与しています。

結論として、EPA市場は、EPAの健康効果に対する消費者の意識の高まり、栄養補助食品や機能性食品に対する需要の高まり、持続可能で植物由来の栄養を求める傾向などを背景に、力強い成長を遂げています。生産と製剤化における技術的進歩に加え、EPAの治療効果に関する継続的な調査により、EPA市場の将来性はさらに高まるとみられます。消費者が健康と幸福を優先するようになるにつれて、EPAを豊富に含む製品に対する需要が高まり、栄養とウェルネスの将来が形成されると予想されます。

セグメント

アプリケーション（栄養補助食品・機能性食品、ペット・動物用飼料、乳児用調製粉乳、医薬品、その他のアプリケーション）

調査対象企業の例（注目の43社）

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17249

Global Eicosapentaenoic Acid Market to Reach US$6.5 Billion by 2030

The global market for Eicosapentaenoic Acid estimated at US$3.5 Billion in the year 2024, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Dietary Supplements & Functional Foods Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Pet & Animal Feeds Application segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$895.0 Million While China is Forecast to Grow at 14.4% CAGR

The Eicosapentaenoic Acid market in the U.S. is estimated at US$895.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Eicosapentaenoic Acid (EPA) Market – Key Trends & Drivers Summarized

What Is Eicosapentaenoic Acid (EPA), And Why Is It Important in Nutrition and Health?

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid primarily found in fatty fish and certain algae. As a polyunsaturated fatty acid, EPA plays a critical role in human health, particularly in supporting cardiovascular function, reducing inflammation, and promoting brain health. EPA is commonly recognized for its anti-inflammatory properties, making it an important nutrient in the management of various health conditions, including cardiovascular diseases, arthritis, and mental health disorders. Additionally, EPA is known to contribute to the synthesis of bioactive compounds called eicosanoids, which help regulate various physiological processes in the body.

The importance of EPA in nutrition is highlighted by its numerous health benefits. Regular consumption of EPA has been linked to improved heart health by lowering triglyceride levels, reducing the risk of arrhythmias, and decreasing blood pressure. Moreover, EPA plays a significant role in mental health, with studies suggesting that adequate levels of this fatty acid may help alleviate symptoms of depression and anxiety. As consumers become more health-conscious, the demand for EPA-rich foods and supplements is on the rise, driving the growth of the EPA market.

What Are the Main Applications of EPA, And How Do They Cater to Nutritional Needs?

Eicosapentaenoic acid (EPA) has several key applications, primarily in dietary supplements, functional foods, pharmaceuticals, and animal nutrition. In the dietary supplement sector, EPA is commonly available in the form of fish oil capsules, krill oil, and algal oil supplements. These products cater to consumers seeking to enhance their omega-3 intake for various health benefits, such as supporting cardiovascular health and reducing inflammation. The popularity of EPA supplements has surged, particularly among health-conscious individuals and those with specific health concerns, leading to a growing market for these products.

In the functional foods segment, EPA is increasingly being incorporated into a variety of food products, including dairy items, beverages, and snack bars. Manufacturers are recognizing the potential market for health-enhancing products that provide added nutritional value. By fortifying everyday foods with EPA, brands can cater to consumers looking for convenient ways to incorporate beneficial omega-3 fatty acids into their diets. This trend is especially relevant as the demand for healthy, functional foods continues to grow among consumers seeking to improve their overall well-being.

EPA is also gaining attention in the pharmaceutical industry, where it is being explored for its therapeutic applications. Research is ongoing to evaluate the efficacy of EPA in managing various medical conditions, including cardiovascular disease, inflammatory disorders, and mental health issues. As new clinical studies emerge, they contribute to the growing body of evidence supporting the health benefits of EPA, potentially leading to new pharmaceutical formulations that incorporate this important fatty acid.

Additionally, the animal nutrition sector is increasingly utilizing EPA in pet foods and aquaculture. In pet nutrition, EPA is being included in dog and cat food formulations to support joint health, skin condition, and overall well-being. The growing trend of premium pet foods, which emphasize health benefits and high-quality ingredients, is driving demand for products fortified with omega-3 fatty acids like EPA. In aquaculture, EPA is crucial for the growth and health of farmed fish, as it enhances feed quality and improves fish health and growth rates. The rising global demand for sustainably farmed seafood is further promoting the use of EPA in aquaculture feeds.

How Are Technological Advancements Impacting the EPA Market?

Technological advancements are significantly influencing the EPA market by improving production methods, extraction processes, and product formulations. One notable development is the innovation in extraction technologies that enhance the yield and quality of EPA from natural sources. Advanced methods, such as supercritical fluid extraction and cold pressing, enable manufacturers to obtain high-purity EPA oils while preserving their beneficial properties. These extraction techniques not only improve the efficiency of EPA production but also reduce the environmental impact associated with traditional extraction methods.

Moreover, the rise of algae-based sources of EPA is transforming the market landscape. As consumers become more aware of sustainability and ethical sourcing, algae-derived EPA products are gaining traction as a viable alternative to fish-based sources. Algal oil, which is rich in both EPA and docosahexaenoic acid (DHA), provides a plant-based option that appeals to vegetarians, vegans, and environmentally conscious consumers. The development of efficient algal cultivation and extraction technologies is supporting the growth of this segment, expanding the availability of EPA-rich products in the market.

Advancements in product formulation are also enhancing the efficacy and bioavailability of EPA supplements. Innovations in emulsification and encapsulation technologies allow for the creation of more stable and bioavailable EPA products that are easier for the body to absorb. These formulations can improve the overall effectiveness of EPA supplements and enhance consumer satisfaction. Additionally, the combination of EPA with other beneficial ingredients, such as DHA, antioxidants, and vitamins, is becoming increasingly common in supplement formulations, catering to consumer preferences for comprehensive health solutions.

Furthermore, digital technology and data analytics are playing a role in improving consumer engagement and product development within the EPA market. Companies are utilizing consumer feedback and market research data to better understand consumer preferences and tailor their product offerings accordingly. This data-driven approach helps manufacturers create targeted marketing strategies and develop innovative EPA products that meet the evolving needs of consumers.

Finally, ongoing research into the health benefits of EPA is leading to new applications and potential therapeutic uses. As scientific studies continue to explore the role of EPA in managing various health conditions, the market is likely to see an expansion of its applications. Increased awareness of the importance of omega-3 fatty acids, along with growing evidence supporting their health benefits, will likely drive demand for EPA-rich products in both consumer and clinical settings.

What Is Driving the Growth in the EPA Market?

The growth in the EPA market is driven by several key factors, including increasing consumer awareness of the health benefits of omega-3 fatty acids, rising demand for dietary supplements, and the expansion of the functional foods sector. One of the primary drivers is the growing recognition of EPA's role in supporting cardiovascular health, reducing inflammation, and promoting brain function. As consumers become more health-conscious and proactive about their well-being, the demand for EPA supplements and fortified products is on the rise.

The increasing prevalence of lifestyle-related health conditions, such as obesity, heart disease, and mental health disorders, is further fueling the demand for EPA. Consumers are seeking preventive health measures, and omega-3 supplementation, particularly with EPA, is increasingly viewed as a beneficial approach to supporting overall health. This trend is particularly prominent among aging populations who are looking for solutions to maintain cognitive function and manage chronic health issues.

The expansion of the functional foods market is another significant factor contributing to the growth of the EPA market. Consumers are increasingly interested in foods that provide additional health benefits, leading to a rise in demand for EPA-fortified products. Manufacturers are responding to this demand by incorporating EPA into a variety of food items, including dairy products, snacks, and beverages. The ability to offer health-enhancing options that fit into consumers' busy lifestyles is driving the growth of this segment.

Additionally, the trend toward sustainable and plant-based diets is promoting interest in algae-derived EPA products. As more consumers adopt vegetarian and vegan lifestyles, the demand for alternative sources of omega-3 fatty acids is rising. Algal oil, rich in both EPA and DHA, presents a sustainable and ethical option for those seeking to increase their omega-3 intake without relying on fish sources. This shift in consumer preferences toward plant-based solutions is likely to continue influencing the EPA market positively.

Finally, ongoing research and clinical studies investigating the therapeutic applications of EPA are driving market growth. As new evidence emerges regarding the potential benefits of EPA in managing specific health conditions, healthcare providers are increasingly recommending omega-3 supplementation. This growing body of research supports the use of EPA in clinical settings, contributing to the broader acceptance and utilization of this essential fatty acid.

In conclusion, the EPA market is experiencing robust growth driven by increasing consumer awareness of its health benefits, rising demand for dietary supplements and functional foods, and the trend toward sustainable and plant-based nutrition. Technological advancements in production and formulation, coupled with ongoing research into the therapeutic potential of EPA, will further enhance the market's prospects. As consumers prioritize their health and well-being, the demand for EPA-rich products is expected to flourish, shaping the future of nutrition and wellness.

SCOPE OF STUDY:

The report analyzes the Eicosapentaenoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Eicosapentaenoic Acid - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Omega-3 Fatty Acids in Dietary Supplements Drives Growth of Eicosapentaenoic Acid (EPA) Market
    • Increased Adoption of EPA in Cardiovascular Health Products Expands Addressable Market
    • Surge in Demand for EPA in Functional Foods and Beverages Fuels Market Growth
    • Technological Advancements in EPA Extraction from Fish and Algae Propel Market Expansion
    • Growing Focus on EPA for Anti-Inflammatory and Joint Health Benefits Strengthens Business Case
    • Rising Use of EPA in Cognitive and Brain Health Supplements Sets the Stage for Market Growth
    • Surge in Adoption of EPA in Sports Nutrition and Fitness Products Expands Market Opportunities
    • Growing Demand for EPA in Infant and Maternal Nutrition Expands Addressable Market
    • Rising Focus on EPA for Eye Health and Vision Support Fuels Market Demand
    • Technological Advancements in Microencapsulation of EPA for Enhanced Stability Propel Market Growth
    • Surge in Demand for EPA in Elderly Care and Cognitive Decline Prevention Expands Market Growth
    • Rising Use of EPA in Animal Nutrition Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Eicosapentaenoic Acid Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pet & Animal Feeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION